Arthritis Research & Therapy

official impact factor 4.36

Open Access

B cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and FcγRIIb, which are modulated by anti-tumor necrosis factor therapy

Diego Catalán, Octavio Aravena, Francisca Sabugo, Pamela Wurmann, Lilian Soto, Alexis M Kalergis, Miguel Cuchacovich, Juan C Aguillón* and Millenium Nucleus on Immunology and Immunotherapy P-07-088-F

Arthritis Research & Therapy 2010, 12:R68 doi:10.1186/ar2985


See related editorial by Mauri and Jury, http://arthritis-research.com/content/12/4/133

Accesses  

  • Last 30 days: 68 accesses
  • Last 365 days: 786 accesses
  • All time: 2698 accesses

Cited by

BioMed Central: 1 citation

Editorial   Free

Could the expression of CD86 and FcγRIIB on B cells be functionally related and involved in driving rheumatoid arthritis?

Claudia Mauri, Elizabeth C Jury Arthritis Research & Therapy 2010, 12:133 (13 August 2010)